Health

A 'Leap' Toward Humanity's Destruction


Wellcome leap

This article initially appeared on Unlimited Hangout.

The world’s richest medical analysis basis, the Wellcome Trust, has teamed up with a pair of former DARPA administrators who constructed Silicon Valley’s skunkworks to usher in an age of nightmarish surveillance, together with for infants as younger as three months previous. Their agenda can solely advance if we permit it.

A UK nonprofit with ties to international corruption all through the COVID-19 disaster in addition to historical and current ties to the UK eugenics motion launched a worldwide health-focused DARPA equal final yr. The transfer went largely unnoticed by each mainstream and impartial media.

The Wellcome Trust, which has arguably been second solely to Bill Gates in its skill to affect occasions in the course of the COVID-19 disaster and vaccination marketing campaign, launched its personal international equal of the Pentagon’s secretive analysis company final yr, formally to fight the “most pressing health challenges of our time.”

Though first conceived of in 2018, this explicit Wellcome Trust initiative was spun off from the Trust last May with $300 million in preliminary funding. It shortly attracted two former DARPA executives, who had beforehand served within the higher echelons of Silicon Valley, to handle and plan its portfolio of tasks.

This international well being DARPA, referred to as Wellcome Leap, seeks to attain “breakthrough scientific and technological solutions” by or earlier than 2030, with a concentrate on “complex global health challenges.” The Wellcome Trust is open about how Wellcome Leap will apply the approaches of Silicon Valley and enterprise capital companies to the well being and life science sector.

Unsurprisingly, their three present applications are poised to develop extremely invasive tech-focused, and in some instances overtly transhumanist, medical applied sciences, together with a program completely centered on utilizing synthetic intelligence (AI), cell sensors, and wearable brain-mapping tech for youngsters three years previous and youthful.

This Unlimited Hangout investigation explores not solely the 4 present applications of Wellcome Leap but in addition the folks behind it. The ensuing image is of an extremely sinister venture that poses not solely an incredible menace to present society however to the way forward for humanity itself. An upcoming Unlimited Hangout investigation will study the historical past of the Wellcome Trust together with its position in latest and present occasions.

Leap’s Leadership: Merging Man and Machine for the Military and Silicon Valley

The ambitions of the Wellcome Leap are made clear by the girl chosen to guide it, former director of the Pentagon’s DARPA, Regina Dugan. Dugan began her career at DARPA in 1996; she led a counterterrorism job pressure in 1999 earlier than leaving DARPA a few yr later.

After departing DARPA, she cofounded her personal enterprise capital agency, Dugan Ventures, after which grew to become particular adviser to the US Army’s vice chief of workers from 2001 to 2003, which coincided with the invasions of Afghanistan and Iraq. In 2005, she created a defense-focused tech agency referred to as RedXDefense, which contracts with the navy and particularly for DARPA.

In 2009, underneath the Obama administration, Dugan was appointed director of DARPA by Defense Secretary Robert Gates. Much was revamped her being the primary feminine director of the company, however she is greatest remembered on the company for her so-called “Special Forces” method to innovation. During her tenure, she created DARPA’s now defunct Transformational Convergence Technology Office, which centered on social networks, artificial biology, and machine intelligence.

Many of the themes beforehand managed by that workplace are actually overseen by DARPA’s Biological Technologies Office, which was created in 2014 and focuses on all the pieces “from programmable microbes to human-machine symbiosis.” The Biological Technologies Office, like Wellcome Leap, pursues a mixture of “health-focused” biotechnology applications and transhumanist endeavors.

Right earlier than leaving the highest position at DARPA, Dugan greenlighted the agency’s initial investments in mRNA vaccine technology, which led to DARPA’s investments in Pfizer and Moderna shortly thereafter. The DARPA scientist who lobbied Dugan to again this system, Dan Wattendorf, now works because the director of Innovative Technology Solutions on the Bill & Melinda Gates Foundation.

While Dugan’s efforts at DARPA are remembered fondly by these within the national-security state, and likewise by these in Silicon Valley, Dugan was investigated for conflicts of curiosity throughout her time as DARPA’s director, as her agency RedXDefense acquired tens of millions in Department of Defense contracts throughout her tenure.

Though she had recused herself from any formal position on the firm whereas main DARPA, she continued to carry a big monetary stake within the firm, and a navy investigation later found she had violated ethics guidelines to a big diploma.

Instead of being held accountable in any manner, Dugan went on to turn out to be a high govt at Google, the place she was introduced on to handle Google’s Advanced Technology and Products Group (ATAP), which it had spun out of Motorola Mobility after Google’s acquisition of that firm in 2012. Google’s ATAP was modeled after DARPA and employed different ex-DARPA officers apart from Dugan.

At Google, Dugan oversaw a number of tasks, together with what’s now the idea of Google’s “augmented reality” enterprise, then referred to as Project Tango, in addition to “smart” clothing through which multitouch sensors had been woven into textiles. Another venture that Dugan led concerned the usage of a “digital tattoo” to unlock smartphones. Perhaps most controversially, Dugan was additionally behind the creation of a “digital authentication pill.”

According to Dugan, when the tablet is swallowed, “your entire body becomes your authentication token.” Dugan framed the tablet and plenty of of her different efforts at Google as working to repair “the mechanical mismatch between humans and electronics” by producing know-how that merges the human physique with machines to various levels.

While serving on this capability at Google, Dugan chaired a panel on the 2013 Clinton Global Initiative referred to as “Game-Changers in Technology” and attended the 2015 Bilderberg meeting the place AI was a most important matter of debate.

In 2016, Dugan left Google for Facebook the place she was chosen to be the primary head of Facebook’s personal DARPA-equivalent analysis company, then referred to as Building 8. DARPA’s ties to the origins of Facebook had been mentioned in a recent Unlimited Hangout report.

Under Dugan, Building 8 invested closely in brain-machine interface know-how, which has since produced the corporate’s “neural wearable” wristbands that declare to have the ability to anticipate actions of the hand and fingers from mind indicators alone. Facebook showcased prototypes of the venture earlier this yr.

Dugan left Facebook simply eighteen months after becoming a member of Building 8, announcing her plans “to focus on building and leading a new endeavor,” which was apparently a reference to Wellcome Leap. Dugan later said it was as if she had been coaching for her position at Wellcome Leap ever since coming into the workforce, framing it as the head of her profession.

When requested in an interview earlier this yr who the purchasers of Wellcome Leap are, Dugan gave a long-winded reply however basically responded that the venture serves the biotech and pharmaceutical industries, worldwide organizations such because the UN, and public-private partnerships.

In addition to her position at Wellcome, Dugan can be a member of the Council on Foreign Relations-sponsored taskforce on US Technology and Innovation coverage, which was fashioned in 2019. Other members embrace LinkedIn’s Reid Hoffman, McKinsey Institute Global Chairman James Manyika, former head of Google Eric Schmidt and President Biden’s controversial high science adviser Eric Lander.

The different govt at Wellcome Leap, chief working officer Ken Gabriel, has a background carefully tied to Dugan’s. Gabriel, like Dugan, is a former program supervisor at DARPA, the place he led the company’s microelectromechanical techniques (MEMS) analysis from 1992 to 1996.

He served as deputy director of DARPA from 1995 to 1996 and have become director of the Electronics Technology Office from 1996 to 1997, the place he was reportedly answerable for about half of all federal electronics-technology investments. At DARPA, Gabriel labored carefully with the FBI and the CIA.

Ken Gabriel
Ken Gabriel – COO of Wellcome Leap. Source: Wellcome Leap

Gabriel left DARPA for Carnegie Mellon University, the place he was accountable for the Office for Security Technologies within the aftermath of September 11, 2001. That workplace was created after 9/11 particularly to assist meet the national-security wants of the federal authorities, in accordance with Carnegie Mellon’s announcement of this system.

Around that very same time, Gabriel grew to become thought to be “the architect of the MEMS industry” on account of his previous work at DARPA and his founding of the MEMS-focused semiconductor firm Akustica in 2002. He served as Akustica’s chairman and chief know-how officer till 2009, at which period he returned to work at DARPA the place he served because the company’s deputy director, working straight underneath Regina Dugan.

In 2012, Gabriel adopted Dugan to Google’s Advanced Technology and Products Group, which he was really answerable for creating. According to Gabriel, Google cofounders Larry Page and Sergey Brin tasked Gabriel with creating “a private sector ground-up model of DARPA” out of Motorola Mobility. Regina Dugan was positioned in cost, and Gabriel once more served as her deputy.

In 2013, Dugan and Gabriel co-wrote a bit for the Harvard Business Review about how DARPA’s “Special Forces” innovation method may revolutionize each the private and non-private sectors if extra broadly utilized.

Gabriel left Google in 2014, nicely earlier than Dugan, to function the president and CEO of Charles Stark Draper Laboratories, higher referred to as Draper Labs, which develops “innovative technology solutions” for the national-security neighborhood, with a concentrate on biomedical techniques, vitality, and area know-how. Gabriel held that place till he abruptly resigned in 2020 to co-lead Wellcome Leap with Dugan.

In addition to his position at Wellcome, Gabriel can be a World Economic Forum “technology pioneer” and on the board of directors of Galvani Bioelectronics, a three way partnership of GlaxoSmithKline, which is intimately linked to the Wellcome Trust, and the Google subsidiary Verily.

Galvani focuses on the event of “bioelectronic medicines” that contain “implant-based modulation of neural signals” in an overt push by the pharmaceutical business and Silicon Valley to normalize transhumanist “medicines.”

The longtime chairman of the board of Galvani, on which Gabriel serves, was Moncef Slaoui, who led the US COVID-19 vaccine growth and distribution program Operation Warp Speed. Slaoui was relieved of his position at Galvani this previous March over well-substantiated claims of sexual harassment.

Jeremy Farrar, Pandemic Narrative Manager

While Dugan and Gabriel ostensibly lead the outfit, Wellcome Leap is the brainchild of Jeremy Farrar and Mike Ferguson, who function its administrators. Farrar is the director of the Wellcome Trust itself, and Ferguson is deputy chair of the Trust’s board of governors.

Farrar has been director of the Wellcome Trust since 2013 and has been actively concerned in vital choice making on the highest degree globally because the starting of the COVID disaster. He can be an agenda contributor to the World Economic Forum and cochaired the WEF’s Africa assembly in 2019.

Farrar’s Wellcome Trust can be a WEF strategic associate and cofounded the COVID Action Platform with the WEF. Farrar was extra just lately behind the creation of Wellcome’s COVID-Zero initiative, which can be tied to the WEF.

Farrar has framed that initiative as “an opportunity for companies to advance the science which will eventually reduce business disruption.” Thus far it has satisfied titans of finance, together with Mastercard and Citadel, to take a position tens of millions in analysis and growth at organizations favored by the Wellcome Trust.

Wellcome Trust Director Jeremy Farrar with NTI Co-Chairman Sam Nunn
Wellcome Trust Director Jeremy Farrar with NTI Co-Chairman Sam Nunn, who led the 2001 Dark Winter exercise.
Source: NTI.com

Some of Wellcome’s controversial medical-research tasks in Africa, in addition to its ties to the UK eugenics motion, had been explored in a December article printed at Unlimited Hangout.

That report additionally explores the intimate connections of Wellcome to the Oxford-AstraZeneca COVID-19 vaccine, the usage of which has now been restricted or banned in a number of nations. As talked about within the introduction, the Wellcome Trust itself is the topic of an upcoming Unlimited Hangout investigation (Part 2).

Jeremy Farrar, who was born in Singapore in 1961, had beforehand been director of the Oxford University Clinical Research Unit in Ho Chi Minh City, starting in 1998. During that point, he authored quite a few epidemiological analysis papers. He claimed in a 2014 Financial Times article that his choice to maneuver to Vietnam was on account of his disdain for convention halls stuffed with white males.

Southeast Asia was clearly a a lot much less regulated surroundings for somebody within the medical-research business wishing to take pleasure in groundbreaking analysis. Although based mostly in Vietnam, Farrar was despatched by Oxford to varied places across the globe to check epidemics taking place in actual time.

In 2009, when swine flu was wreaking havoc in Mexico, Farrar jumped on a plane to dive proper into the motion, one thing he additionally did for subsequent international outbreaks of Ebola, MERS, and avian flu.

Over the previous yr, many questions have arisen relating to precisely how a lot energy Farrar wields over international public well being coverage. Recently, the US president’s chief medical adviser, Anthony Fauci, was compelled to launch his emails and correspondence from March and April 2020 on the request of the Washington Post.

The launched emails reveal what seems to be a high-level conspiracy by a number of the high medical authorities within the US to falsely declare that COVID-19 may solely have been of zoonotic origin, regardless of indications on the contrary. The emails had been closely redacted as such emails normally are, supposedly to guard the information of the folks concerned, however the “(b)(6)” redactions additionally defend a lot of Jeremy Farrar’s enter into these discussions.

Chris Martenson, financial researcher and post-doctorate pupil of neurotoxicology and founding father of Peak Prosperity, has had some insightful feedback on the matter, together with asking why such safety has been supplied to Farrar given that he’s the director of a “charitable trust.” Martenson went on to query why the Wellcome Trust was concerned in any respect in these high-level discussions.

One Fauci e-mail, dated February 25, 2020, and despatched by Amelie Rioux of the WHO, acknowledged that Jeremy Farrar’s official position at the moment was “to act as the board’s focal point on the COVID-19 outbreak, to represent and advise the board on the science of the outbreak and the financing of the response.”

Farrar had previously chaired the WHO’s Scientific Advisory Council. The emails additionally present the preparation, inside a ten-day interval, of the SARS-CoV-2 “‘origins” paper, which was entitled “The Proximal Origin of SARS-CoV-2” and was accepted for publication by Nature Medicine on March 17, 2020.

The paper claimed that the SARS-CoV-2 virus may solely have come from pure origins versus gain-of-function analysis, a declare as soon as held as gospel within the mainstream however which has come underneath appreciable scrutiny in latest weeks.

Shaping the presentation of an origin story for a virus of worldwide significance is one thing Farrar has been concerned with earlier than. In 2004–5, it was reported that Farrar and his Vietnamese colleague Tran Tinh Hien, the vice director on the Hospital for Tropical Diseases, had been the primary to determine the re-emergence of the avian flu (H5N1) in people.

Farrar has recounted the origin story on many events, stating: “It was a little girl. She caught it from a pet duck that had died and she’d dug up and reburied. She survived.” According to Farrar, this expertise prompted him to discovered a worldwide community together with the World Health Organization to “improve local responses to disease outbreaks.”

An article printed by Rockefeller University Press’s Journal of Experimental Medicine in 2009 is dramatically titled, “Jeremy Farrar: When Disaster Strikes.” Farrar, when referring to the H5N1 origin story stated: “The WHO folks—and this isn’t a criticism—determined it was unlikely that the kid had SARS or avian influenza.

They left, however Professor Hien stayed behind to speak with the kid and her mum. The woman admitted that she had been fairly unhappy within the earlier days with the loss of life of her pet duck. The woman and her brother had fought over burying the duck and, due to this argument, she had gone again, dug up the duck, and reburied it—in all probability so her brother would not know the place it was buried.

With that historical past, Professor Hien phoned me at residence and mentioned he was anxious concerning the youngster. He took some swabs from the kid’s nostril and throat and introduced them again to the hospital. That night time the laboratory ran assessments on the samples, and so they had been constructive for Influenza A.”

With Farrar now having been revealed as an instrumental a part of the crew that crafted the official story relating to the origins of SARS-CoV-2, his earlier assertions concerning the origin of previous epidemics must be scrutinized.

As the director of a “charitable trust,” Jeremy Farrar is sort of fully unaccountable for his involvement in crafting controversial narratives associated to the COVID disaster. He continues to be on the forefront of the worldwide response to COVID, partially by launching the Wellcome Leap Fund for “unconventional projects, funded at scale” as an overt try to create a worldwide and “charitable” model of DARPA.

Indeed, Farrar, in conceiving Wellcome Leap, has positioned himself to be simply as, if no more, instrumental in constructing the muse for the post-COVID period as he was in constructing the muse for the COVID disaster itself.

This is important as Wellcome Leap CEO Regina Dugan has labeled COVID-19 this era’s “Sputnik moment” that can launch a brand new age of “health innovation,” very similar to the launching of Sputnik began a worldwide technological “space age.” Wellcome Leap totally intends to guide the pack.

“Rulers” of the Gene-Sequencing Industry

In distinction to the overt DARPA, Silicon Valley, and Wellcome connections of the others, the chairman of the board of administrators of Wellcome Leap, Jay Flatley, has a unique background. Flatley is the long-time head of Illumina, a California-based gene-sequencing {hardware} and software program large that’s believed to at the moment dominate the sector of genomics.

Though he stepped down from the board of Illumina in 2016, he has continued to function the manager chairman of its board of administrators. Flatley was the primary to be chosen for a management place at Wellcome Leap, and he was answerable for suggesting Regina Dugan for the group’s chief govt officer, in accordance with a recent interview given by Dugan.

Illumina Campus
Illumina Campus. Source: Glassdoor

As a profile on Illumina within the enterprise journal Fast Company notes, Illumina “operates behind the scenes, selling hardware and services to companies and research institutions,” amongst them 23andMe. 23andMe’s CEO, Anne Wojcicki, the sister of YouTube CEO Susan Wojcicki and the spouse of Google cofounder Sergey Brin, informed Fast Company, “It’s crazy. Illumina is like the ruler of this whole universe and no one knows that.”

The report notes that 23andMe, like most firms that provide DNA sequencing and evaluation to customers, makes use of machines produced by Illumina.

In 2016, Illumina launched an “aggressive” five-year plan to “bring genomics out of research labs and into doctors’ offices.” Given the present state of issues, notably the worldwide push towards gene-focused vaccines and therapies, that plan, which concludes this yr, couldn’t have been any higher timed.

Illumina’s present CEO, Francis DeSouza, previously held key posts at Microsoft and Symantec. Also in 2016, Illumina’s govt groups forecast a future through which people are gene examined from delivery to grave for each well being and business functions.

Whereas most firms have struggled financially in the course of the coronavirus pandemic, some have seen an enormous enhance in earnings. Illumina has witnessed its share price double because the begin of the COVID disaster.

The firm’s $1 billion plus in earnings over the past tax yr was clearly helped by the fast approval of the NovaSEQ 6000 machines, which may take a look at a large number of COVID samples extra shortly than different gadgets. An particular person machine has a hefty price ticket of virtually $1 million, and thus they’re principally discovered at elite facilities, private labs, and top-tier universities.

Jay Flatley
Jay Flatley, Executive Chairman, Illumina, talking at World Economic Forum in Davos 2018. Source: WEF

In addition to his long-standing management position at Illumina, Jay Flatley can be a “digital member” of the World Economic Forum in addition to the lead independent director of Zymergen, a WEF “tech pioneer” firm that’s “rethinking biology and reimagining the world.”

Flatley, who has additionally attended a number of Davos conferences, has addressed the WEF on the “promise of precision [i.e., gene-specific] medicine.”

At another WEF panel meeting, Flatley, alongside UK Health Secretary Matt Hancock, promoted the thought of constructing genomic sequencing of infants at delivery the norm, claiming it had “the potential to shift the healthcare system from reactive to preventative.”

Some on the panel referred to as for the genomic sequencing of infants to finally turn out to be necessary.

Aside from Flatley as a person, Illumina as an organization is a WEF partner and performs a key position in its platform relating to the way forward for well being care. A high Illumina govt also serves on the WEF’s Global Future Council on Biotechnology.

A New HOPE

Wellcome Leap at the moment has 4 applications: Multi-Stage Psych, Delta Tissue, 1KD, and HOPE. HOPE was the primary program to be introduced by Wellcome Leap and stands for Human Organs, Physiology and Engineering. According to the complete program description, HOPE goals “to leverage the power of bioengineering to advance stem cells, organoids, and whole organ systems and connections that recapitulate human physiology in vitro and restore vital functions in vivo.”

human organs physiology and engineering
Source: Wellcome Leap, https://wellcomeleap.org/hope/

HOPE consists of two main program goals. First, it seeks to “bioengineer a multiorgan platform that recreates human immunological responses with sufficient fidelity to double the predictive value of a preclinical trial with respect to efficacy, toxicity and immunogenicity for therapeutic interventions.”

In different phrases, this bioengineered platform mimicking human organs can be used to check the results of pharmaceutical merchandise, together with vaccines, which may create a scenario through which animal trials are changed with trials on gene-edited and farmed organs.

Though such an advance will surely be useful within the sense of decreasing usually unethical animal experimentation, trusting such a novel system to permit medical remedies to go straight to the human-testing section would additionally require trusting the establishments creating that system and its funders.

As it stands now, the Wellcome Trust has too many ties to deprave actors within the pharmaceutical business, having initially begun because the “philanthropic” arm of UK drug large GlaxoSmithKline, for anybody to belief what they’re producing with out precise impartial affirmation, given the histories of a few of their companions in fudging each animal and human scientific trial information for vaccines and different merchandise.

The second aim of HOPE is to open up the usage of machine-human hybrid organs for transplantation into human beings. That aim focuses on restoring “organ functions using cultivated organs or biological/synthetic hybrid systems” with the later aim of bioengineering a completely transplantable human organ after a number of years.

Later on in this system description, nonetheless, the curiosity in merging the artificial and organic turns into clearer when it states: “The time is right to foster synergies between organoids, bioengineering and immunoengineering technologies, and advance the state-of-the-art of in vitro human biology … by building controllable, accessible and scalable systems.”

The program description doc additionally notes the curiosity of Wellcome in genetic-engineering approaches for the “enhancement of desired properties and insertion of traceable markers” and Wellcome’s ambition to breed the constructing blocks of the human immune system and human organ techniques by technological means.

Transhumanist Toddlers?

The second program to be pursued by Wellcome Leap is named “The First 1000 Days: Promoting Healthy Brain Networks,” which is abbreviated as 1KD by the group. It is arguably probably the most unsettling program as a result of it seeks to make use of younger youngsters, particularly infants from three months to three-year-old toddlers, as its take a look at topics.

The program is being overseen by Holly Baines, who beforehand served as technique growth lead for the Wellcome Trust earlier than becoming a member of Wellcome Leap because the 1KD program chief.

the first 1000 days
Source: Wellcome Leap, https://wellcomeleap.org/1kd/

1KD is focused on creating “objective, scalable ways to assess a child’s cognitive health” by monitoring the mind growth and performance of infants and toddlers, permitting practitioners to “risk-stratify children” and “predict responses to interventions” in creating brains.

The program description doc notes that, up thus far in historical past, “our primary window into the developing brain has been neuroimaging techniques and animal models, which can help identify quantitative biomarkers of [neural] network health and characterise network differences underlying behaviours.” It then states that advances in know-how “are opening additional possibilities in young infants.”

The program description goes on to say that synthetic neural networks, a type of AI, “have demonstrated the viability of modelling network pruning process and the acquisition of complex behaviours in much the same way as a developing brain,” whereas enhancements in machine studying, one other subset of AI, can now be used to extract “meaningful signals” from the brains of infants and younger youngsters.

These algorithms can then be used to develop “interventions” for younger youngsters deemed by different algorithms to be at risk of getting underdeveloped mind perform.

The doc goes on to notice the promise of “low-cost mobile sensors, wearables and home-based systems” in “providing a new opportunity to assess the influence and dependency of brain development on natural physical and social interactions.”

In different phrases, this program seeks to make use of “continuous visual and audio recordings in the home” in addition to wearable gadgets on youngsters to gather tens of millions upon tens of millions of information factors. Wellcome Leap describes these wearables as “relatively unobtrusive, scalable electronic badges that collect visual, auditory and motion data as well as interactive features (such as turn-taking, pacing and reaction times).”

Elsewhere within the doc there’s a name to develop “wearable sensors that assess physiological measures predictive of brain health (e.g., electrodermal activity, respiratory rate, and heart rate) and wireless wearable EEG or eye-tracking technology” to be used in infants and youngsters three and underneath.

Like different Wellcome Leap applications, this know-how is being developed with the intention of constructing it mainstream in medical science throughout the subsequent 5 to 10 years, which means that this technique—though framed as a solution to monitor youngsters’s mind functioning to enhance cognitive outcomes—is a recipe for complete surveillance of infants and really younger youngsters in addition to a way for altering their mind functioning as algorithms and Leap’s programmers see match.

1DK has two most important program objectives. The first is to “develop a fully integrated model and quantitive measurement tools of network development in the first 1000 days [of life], sufficient to predict EF [executive function] formation before a child’s first birthday.”

Such a mannequin, the outline reads, “should predict contributions of nutrition, the microbiome and the genome” on mind formation in addition to the results of “sensimotor and social interactions [or lack thereof] on network pruning processes” and EF outcomes. The second aim makes it clear that widespread adoption of such neurological-monitoring applied sciences in younger youngsters and infants is the endgame for 1DK.

It states that this system plans to “create scalable methods for optimising promotion, prevention, screening and therapeutic interventions to improve EF by at least 20% in 80% of children before age 3.”

True to the eugenicist ties of the Wellcome Trust (to be explored extra in-depth in Part 2), Wellcome Leap’s 1DK notes that “of interest are improvements from underdeveloped EF to normative or from normative to well-developed EF across the population to deliver the broadest impact.”

One of the objectives of 1DK is thus not treating illness or addressing a “global health public challenge” however as a substitute experimenting on the cognitive augmentation of kids utilizing means developed by AI algorithms and invasive surveillance-based know-how.

Another unsettling side of this system is its plan to “develop an in vitro 3D brain assembloid that replicates the time formation” of a creating mind that’s akin to the fashions developed by monitoring the mind growth of infants and youngsters.

Later on, this system description calls this an “in-silico” mannequin of a kid’s mind, one thing of apparent curiosity to transhumanists who see such a growth as a harbinger of the so-called singularity.

Beyond that, it seems that this in-silico and thus artificial mannequin of the mind is deliberate for use because the “model” to which toddler and youngsters brains are formed by the “therapeutic interventions” talked about elsewhere in this system description.

It must be clear how sinister it’s that a corporation that brings collectively the worst “mad scientist” impulses of each the NGO and military-research worlds is brazenly planning to conduct such experiments on the brains of infants and toddlers, viewing them as datasets and their brains as one thing to be “pruned” by machine “intelligence.”

Allowing such a program to advance unimpeded with out pushback from the general public would imply allowing a harmful agenda focusing on society’s youngest and most susceptible members to doubtlessly advance to some extent the place it’s troublesome to cease.

A “Tissue Time Machine”

The third and second-most latest program to hitch the Wellcome Leap lineup is named Delta Tissue, abbreviated by the group as ΔT. Delta Tissue goals to create a platform that screens modifications in human-tissue perform and interactions in actual time, ostensibly to “explain the status of a disease in each person and better predict how that disease would progress.”

Referring to this platform as a “tissue time machine,” Wellcome Leap sees Delta Tissue as with the ability to predict the onset of illness earlier than it happens whereas additionally permitting for medical interventions that “are targeted to the individual.”

delta tissue
Source: Wellcome Leap, https://wellcomeleap.org/delta-tissue/

Well earlier than the COVID period, precision drugs or drugs “targeted or tailored to the individual” has been a code phrase for remedies based mostly on sufferers’ genetic information and/or for remedies that alter nucleic acid (e.g., DNA and RNA) perform itself. For occasion, the US authorities defines “precision medicine” as “an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person.”

Similarly, a 2018 paper printed in Technology notes that, in oncology, “precision and personalized medicine … fosters the development of specialized treatments for each specific subtype of cancer, based on the measurement and manipulation of key patient genetic and omic data (transcriptomics, metabolomics, proteomics, etc.).”

Prior to COVID-19 and the vaccine roll outs, the mRNA vaccine know-how utilized by the DARPA-funded firms Moderna and Pfizer had been marketed as being precision medicine treatments and had been largely known as “gene therapies” in media stories.

They had been additionally promoted closely as a revolutionary methodology of treating most cancers, making it unsurprising that the Delta Tissue program at Wellcome Leap would use an analogous justification to develop a program that goals to supply tailor-made gene therapies to folks earlier than the onset of a illness.

This Delta Tissue platform works to mix “the latest cell and tissue profiling technologies with recent advances in machine learning,” that’s, AI.

Given Wellcome Leap’s connections to the US navy, it’s price noting that the Pentagon and Google, each former employers of Wellcome Leap CEO Regina Dugan and COO Ken Gabriel, have been working collectively since final September on utilizing AI to foretell illness in people, first specializing in most cancers earlier than increasing to COVID-19 and each illness in between.

The Delta Tissue program seems to have associated ambitions, as its program description makes clear that this system finally goals to make use of its platform for a number of cancers and infectious illnesses.

The final aim of this Wellcome Leap program is “to eradicate the stubbornly challenging diseases that cause so much suffering around the world.” It plans to do that by AI algorithms, nonetheless, that are by no means 100% correct of their predictive skill, and with gene-editing remedies, practically all of that are novel and haven’t been nicely examined.

That latter level is essential provided that one of many most important strategies for gene-editing in people, CRISPR, has been present in quite a few research to trigger appreciable injury to the DNA, injury that’s largely irreparable (see here, here and here).

It appears believable that an individual positioned on such a hi-tech medical therapy path will proceed to wish a endless sequence of gene-editing remedies and maybe different invasive hi-tech remedies to mitigate and handle the results of clumsy gene splicing.

Total Surveillance to Treat “Depression”

Wellcome Leap’s most up-to-date program, launched simply this week, is named “Multi-Channel Psych: Revealing Mechanisms of Anhedonia” and is formally centered on creating “complex, biological” remedies for despair.

multi channel psych
Source: Wellcome Leap, https://wellcomeleap.org/mcpsych/

Those behind Wellcome Leap frame the problem they purpose to sort out with this program as follows:

“We perceive that synaptic connections function the forex of neural communication, and that strengthening or weakening these connections can facilitate studying new behavioral methods and methods of trying on the world.

Through research in each animal fashions and people, we have now found that emotional states are encoded in advanced neural community exercise patterns, and that straight altering these patterns through mind stimulation can shift temper. We additionally know that disruption of those delicately balanced networks can result in neuropsychiatric sickness.” (emphasis added)

They add that “biologically based treatments” for despair “are not being matched to the biology of the human beings they’re being used in,” and, thus, remedies for despair must be tailor-made “to the specific biology” of particular person sufferers. They clearly state that what must be addressed as a way to make such private modifications to therapy is to achieve “easy access to the biological substrate of depression—i.e. the brain.”

Wellcome Leap’s program description notes that this effort will focus particularly on anhedonia, which it defines as “an impairment in the effort-based reward system” and as a “key symptom of depression and other neuropsychiatric illnesses.” Notably, within the high-quality print of the doc, Wellcome Leap states:

“While there are many definitions of anhedonia, we are less interested in the investigation of reduced consummatory pleasure, the general experience of pleasure, or the inability to experience pleasure. Rather, as per the description above, we will prioritize investigations of anhedonia as it relates to impairments in the effort-based reward system—e.g. reduced motivation to complete tasks and decreased capacity to apply effort to achieve a goal.”

In different phrases, Wellcome Leap is barely fascinated with treating facets of despair that intrude with a person’s skill to work, not in bettering a person’s high quality or enjoyment of life.

Leap notes, in discussing its objectives, that it seeks to develop fashions for the way sufferers reply to remedies that embrace “novel or existing behavior modification, psychotherapy, medication, and neurostimulation options” whereas additionally capturing a person’s “genome, phenome [the sum of an individual’s phenotypic traits], [neural] network connectivity, metabolome [the sum of an individual’s metabolic traits], microbiome, reward processing plasticity levels,” amongst others.

It finally goals to foretell the connection between a person’s genome to how “reward processing” capabilities within the mind. It implies that the information used to create this mannequin ought to contain the usage of wearables, stating that researchers “should seek to leverage high frequency patient-worn or in-home measurements in addition to those obtained in the clinic, hospital or laboratory.”

One of the primary analysis areas included in this system seems to be to “develop new scalable measurement tools for reliable and high-density quantification of mood (both subjectively reported and objectively quantified via biometrics such as voice, facial expression, etc.), sleep, movement, reward system functioning, effort/motivation/energy levels, social interaction, caloric intake, and HPA axis output in real-world situations.”

The HPA (hypothalamic-pituitary-adrenal) axis is talked about all through the doc, and that is vital as it’s each a adverse and constructive suggestions system regulating the mechanisms of stress reactions, immunity, and likewise fertility within the human physique.

The latter is very essential given the Wellcome Trust’s ties to the UK eugenics motion. It can be price noting that some commercially out there wearables, comparable to Amazon’s Halo, already quantify temper, sleep, and motion.

The program’s authors go even additional than the above when it comes to what they want to monitor in actual time, stating, “We specifically encourage the development of non-invasive technology to directly interrogate human brain state.” Examples embrace “a non-invasive spinal tap equivalent,” “behavioral or biomarker probes of neural plasticity,” and “single-session neural monitoring capabilities that define a treatment-predictive brain state.”

In different phrases, this Wellcome Leap program and its authors search to develop “non-invasive” and, possible, wearable know-how able to monitoring a person’s temper, facial expressions, social interactions, effort and motivation, and doubtlessly even ideas as a way to “directly interrogate human brain state.”

To assume that such a tool would keep solely within the realm of analysis is naive, particularly provided that WEF luminaries have openly spoken at Davos meetings about how governments plan to make use of such know-how broadly on their populations as a way of pre-emptively focusing on would-be dissent and ushering in an period of “digital dictatorships.”

The concentrate on treating solely the facets of despair that intrude with an individual’s work additional means that such know-how, as soon as developed, can be used to make sure “perfect worker” conduct in industries the place human employees are quickly being changed with AI and machines, which means the rulers will be extra selective about which individuals proceed to be employed and which don’t.

Like different Wellcome Leap applications, if accomplished, the fruits of the Multi-Channel Psych program will possible be used to make sure a inhabitants of docile automatons whose actions and ideas are closely surveilled and monitored.

The Last Leap for an Old Agenda

Wellcome Leap isn’t any small endeavor, and its administrators have the funding, affect, and connections to make their desires actuality. The group’s management contains the important thing pressure behind Silicon Valley’s push to commercialize transhumanist tech (Regina Dugan), the “architect” of the MEMS business (Ken Gabriel), and the “ruler” of the burgeoning genetic-sequencing business (Jay Flatley).

It additionally advantages from the funding of the world’s largest medical-research basis, the Wellcome Trust, which can be one of many main forces in shaping genetics and biotechnology analysis in addition to well being coverage globally.

A 1994 Sunday Times investigation into the Trust famous that “through [Wellcome Trust] grants and sponsorships, government agencies, universities, hospitals and scientists are influenced all over the world. The trust distributes more money to institutions than even the British government’s Medical Research Council.” It then notes:

“In offices on the building’s first floor, decisions are reached that affect lives and health on scales comparable with minor wars. In the conference room, high above the street, and in the meeting hall, in the basement, rulings in biotechnology and genetics are handed down that will help shape the human race.”

Little has modified relating to the Trust’s affect since that article was printed. If something, its affect on analysis paths and selections that can “shape the human race” has solely grown. Its ex-DARPA officers, who’ve spent their careers advancing transhumanist know-how in each the private and non-private sectors, have overlapping objectives with these off Wellcome Leap.

Dugan’s and Gabriel’s business tasks in Silicon Valley reveal that Leap is led by those that have lengthy sought to advance the identical know-how for revenue and for surveillance. This drastically weakens Wellcome Leap’s declare to now be pursuing such applied sciences to solely enhance “global health.”

type from your brain
Regina Dugan’s Keynote at Facebook F8 2017. Source: YouTube

Indeed, as this report has proven, most of those applied sciences would usher in a deeply disturbing period of mass surveillance over each the exterior and inner actions of human beings, together with younger youngsters and infants, whereas additionally creating a brand new period of drugs based mostly largely on gene-editing therapies, the dangers of that are appreciable and likewise persistently downplayed by its promoters.

When one understands the intimate bond that has lengthy existed between eugenics and transhumanism, Wellcome Leap and its ambitions make excellent sense. In a latest article written by John Klyczek for Unlimited Hangout, it was famous that the primary director common of UNESCO and former president of the UK Eugenics Society was Julian Huxley, who coined the time period “transhumanism” in his 1957 e book New Bottles for New Wine.

As Klyczek wrote, Huxley argued that “the eugenic goals of biologically engineering human evolution should be refined through transhumanist technologies, which combine the eugenic methods of genetic engineering with neurotech that merges humans and machines into a new organism.”

Earlier, in 1946, Huxley noted in his vision for UNESCO that it was important that “the eugenic problem is examined with the greatest care and that the public mind is informed of the issues at stake so that much that is now unthinkable may at least become thinkable,” an astounding assertion to make so quickly after the top of World War II.

Thanks largely to the Wellcome Trust and its affect on each coverage and medical analysis over the course of a number of many years, Huxley’s dream of rehabilitating eugenics-infused science within the put up–World War II period may quickly turn out to be actuality. Unsurprisingly, the Wellcome Trust hosts the archive of the previously Huxley-led Eugenics Society and still boasts close ties to its successor group, the Galton Institute.

The over-riding query is: Will we permit ourselves to proceed to be manipulated into permitting transhumanism and eugenics to be brazenly pursued and normalized, together with by initiatives like these of Wellcome Leap that search to make use of infants and toddlers as take a look at topics to advance their nightmarish imaginative and prescient for humanity?

If well-crafted promoting slogans and media campaigns portray visions of utopia comparable to “a world without disease” are all that’s wanted to persuade us to surrender our future and our youngsters’s future to navy operatives, company executives, and eugenicists, then there may be little left of our humanity to give up.

aggbug

Source Link – articles.mercola.com

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

8 + thirteen =

Back to top button